Aerolase Neo Elite for Rosacea: Clinical Insights from Dr. Dara Spearman | AAD 2026
Dr. Dara Spearman shares her clinical protocols for treating rosacea with the Aerolase Neo Elite — including treatment frequency, patient selection, and outcomes.
At AAD 2026, board-certified dermatologist Dr. Dara Spearman of Radiant Dermatology Associates (Fort Wayne, Indiana) shares her clinical experience using the Aerolase Neo Elite for rosacea treatment — one of the most common indications she treats in her practice.
In this presentation, Dr. Spearman covers:
- Why the Neo Elite is her go-to for rosacea — including erythema, telangiectasias, and spider angiomas
- Treatment protocols — typical series of 6 sessions, spaced 3–4 weeks apart, with annual maintenance
- Patient selection and full-face treatment rationale — and how she uses before/after photos to guide expansion of treatment areas
- Tolerability advantages — why patients who can't tolerate other modalities do well with the Neo Elite
- Practice workflow — how she delegates treatments to aestheticians without compromising clinical outcomes
- Sun protection counseling — protecting patient investment between sessions
The Aerolase Neo Elite uses a 650-microsecond 1064nm Nd:YAG pulse to selectively target vascular structures with minimal thermal injury to surrounding tissue — making it a well-tolerated option for rosacea patients across skin types.
Presented by Dara Spearman, MD
Dr. Dara Spearman is a board-certified dermatologist and founder of Radiant Dermatology Associates in Fort Wayne, Indiana. She specializes in laser-based treatments for common dermatologic conditions including rosacea and has incorporated the Aerolase Neo Elite into her daily practice workflow since 2023.


